Showing results (941-950 of 4,560) with videos related to
Sort By:
Pageof 456
Neuropsychiatric Disease and Treatment|February 1, 2023
Personal and Social Functioning and Health-Related Quality of Life in Patients with Schizophrenia Treated with the Long-Acting Injectable Antipsychotic Risperidone ISMRobert Litman, Dieter Naber, Lourdes Anta, et al.Neuropsychiatric Disease and Treatment|February 28, 2023
Systemic Immune-Inflammation Index is Associated with Cerebral Small Vessel Disease Burden and Cognitive ImpairmentYining Xiao, Zhenjie Teng, Jing Xu, et al.Neuropsychiatric Disease and Treatment|March 13, 2023
Resilience and Quality of Life in People with Mental Illness: A Systematic Review and Meta-AnalysisShu Ping Chuang, Jo Yung Wei Wu, Chien Shu WangNeuropsychiatric Disease and Treatment|March 14, 2023
Serum TSH Levels are Associated with Hyperactivity Behaviors in Children with Attention Deficit/Hyperactivity DisorderGuanru Chen, Wenfan Gao, Yayun Xu, et al.Neuropsychiatric Disease and Treatment|March 6, 2023
Effects of Adjunctive Betahistine Therapy on Lipid Metabolism in Patients with Chronic Schizophrenia: A Randomized Double-Blind Placebo-Controlled StudyLuyuan Bai, Weiye Liang, Yongqian Wang, et al.Neuropsychiatric Disease and Treatment|March 6, 2023
Validation of the THINC-It Tool for Assessment of Cognitive Impairment in Patients with Bipolar DepressionNa Zhu, WeiHua Zhang, Jia Huang, et al.Neuropsychiatric Disease and Treatment|March 7, 2023
Gender Dysphoria: Optimizing Healthcare for Transgender and Gender Diverse Youth with a Multidisciplinary ApproachClaire A Coyne, Briahna T Yuodsnukis, Diane ChenNeuropsychiatric Disease and Treatment|March 7, 2023
Literature Overview of the Relation Between Psoriasis and AlzheimerQian Yang, Jing Wang, Ningyu Mi, et al.Neuropsychiatric Disease and Treatment|March 23, 2023
Research Hotspots and Global Trends of Transcranial Direct Current Stimulation in Stroke: A Bibliometric AnalysisKebing Zhou, Yu Zhou, Yuena Zeng, et al.Neuropsychiatric Disease and Treatment|November 17, 2022
Effectiveness of Lurasidone 80 mg in Patients with Schizophrenia: Results of an Open-Label, 12-Week Extension StudyItaru Miura, Kei Watabe, Reiko Sakaguchi, et al.Pageof 456